Metraipolis › archive › dc_ab032e748371

The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19 — Europe PMC PMID:40688075

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40688075
DOI
10.3389/fimmu.2025.1594373
License (as archived)
solo-consultazione
Archived
2026-10-08T07:45:29.640Z
SHA-256 of the archived text
f0c17bd25c819c888a60a64f4351de9ccc8905de02c69d079d03b09bb5c27a19
Stable URL of this page
https://metraipolis.com/documento/dc_ab032e748371

How to cite

The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19 — Europe PMC PMID:40688075 — Europe PMC (en), https://europepmc.org/article/MED/40688075 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab032e748371 (Metraipolis archive dc_ab032e748371, sha256 f0c17bd25c819c888a60a64f4351de9ccc8905de02c69d079d03b09bb5c27a19)
BibTeX
@misc{dcab032e748371,
  title = {The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19 — Europe PMC PMID:40688075},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40688075},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab032e748371; sha256 f0c17bd25c819c888a60a64f4351de9ccc8905de02c69d079d03b09bb5c27a19},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40688075. Agents can read the archived copy with the MCP tool read_document.